4.6 Article

Gap junction protein beta 4 plays an important role in cardiac function in humans, rodents, and zebrafish

Journal

PLOS ONE
Volume 15, Issue 10, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0240129

Keywords

-

Funding

  1. Ministry of Education, Science, Technology, Sports and Culture, Japan
  2. Mie Medical Foundation [19K08578]
  3. Okasankato Culture Shinkozaidan Foundation
  4. Mie medical association
  5. Mie University Graduate School of Medicine
  6. BristolMyers Squibb
  7. Daiichi Sankyo Pharmaceutical Co., Ltd.
  8. Shionogi Co., Ltd.
  9. Sumitomo Dainippon Pharma Co., Ltd.
  10. Mitsubishi Tanabe Corporation
  11. Otsuka Pharmaceutical Co., Ltd.
  12. Bayer Yakuhin, Ltd.
  13. Boehringer Ingelheim Co., Ltd.
  14. Takeda Pharmaceutical Co., Ltd.

Ask authors/readers for more resources

Aims GJB4 encodes a transmembrane connexin protein (Cx30.3) that is a component of gap junctions. This study investigated whether GJB4 plays an important role in human heart disease and function. Methods and results We examined a patient and her older brother who both presented with complicated severe hypertrophic cardiomyopathy (HCM) and whose parents are healthy married cousins. The gene exome analysis showed 340 single nucleotide polymorphisms (SNPs) that caused amino acid changes for which the patient was homozygous and both parents were heterozygous. After excluding all known common (>10%) SNP gene mutations, the gene for GJB4 was the only identified gene that is possibly associated with cardiac muscle. The resultant E204A substitution exists in the 4th transmembrane domain. GJB4-E204A impaired the binding with gap junction protein A1 (GJA1) compared with GJB4-WT. The expression of GJB4 was induced in rat disease models of left and right ventricle hypertrophy and mouse disease models of adriamycin-induced cardiomyopathy and myocardial infarction, while it was not detected at all in control. An immunohistochemical study was performed for autopsied human hearts and the explanted heart of the patient. GJB4 was expressed and colocalized with GJA1 in intercalated discs in human diseased hearts, which was extensively enhanced in the explanted heart of the patient. The abnormal expression and localization of GJB4 were observed in beating spheres of patient's induced pluripotent stem cell (iPSC)-derived cardiomyocytes (CMs). We generated knockout zebrafish ofGJB4by CRISPR/Cas9 and the endodiastolic volume and the ventricular ejection fraction were significantly lower in GJB4-deficient than in wild-type zebrafish at five days post-fertilization. Conclusions These results indicate both that GJB4 is defined as a new connexin in diseased hearts, of which mutation can cause a familial form of HCM, and that GJB4 may be a new target for the treatment of cardiac hypertrophy and dysfunction.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available